Cargando…

An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients

Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheichel, Florian, Pinggera, Daniel, Popadic, Branko, Sherif, Camillo, Marhold, Franz, Freyschlag, Christian Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065338/
https://www.ncbi.nlm.nih.gov/pubmed/35515113
http://dx.doi.org/10.3389/fonc.2022.884724
_version_ 1784699564301746176
author Scheichel, Florian
Pinggera, Daniel
Popadic, Branko
Sherif, Camillo
Marhold, Franz
Freyschlag, Christian Franz
author_facet Scheichel, Florian
Pinggera, Daniel
Popadic, Branko
Sherif, Camillo
Marhold, Franz
Freyschlag, Christian Franz
author_sort Scheichel, Florian
collection PubMed
description Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients.
format Online
Article
Text
id pubmed-9065338
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90653382022-05-04 An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients Scheichel, Florian Pinggera, Daniel Popadic, Branko Sherif, Camillo Marhold, Franz Freyschlag, Christian Franz Front Oncol Oncology Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients. Frontiers Media S.A. 2022-04-20 /pmc/articles/PMC9065338/ /pubmed/35515113 http://dx.doi.org/10.3389/fonc.2022.884724 Text en Copyright © 2022 Scheichel, Pinggera, Popadic, Sherif, Marhold and Freyschlag https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Scheichel, Florian
Pinggera, Daniel
Popadic, Branko
Sherif, Camillo
Marhold, Franz
Freyschlag, Christian Franz
An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_full An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_fullStr An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_full_unstemmed An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_short An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
title_sort update on neurosurgical management of primary cns lymphoma in immunocompetent patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065338/
https://www.ncbi.nlm.nih.gov/pubmed/35515113
http://dx.doi.org/10.3389/fonc.2022.884724
work_keys_str_mv AT scheichelflorian anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT pinggeradaniel anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT popadicbranko anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT sherifcamillo anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT marholdfranz anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT freyschlagchristianfranz anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT scheichelflorian updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT pinggeradaniel updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT popadicbranko updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT sherifcamillo updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT marholdfranz updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients
AT freyschlagchristianfranz updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients